Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Generation of vaccine-primed lymphocytes for the treatment of head and neck cancer.

Head & neck - 1 Mar 2003

Chang Alfred E, Li Qiao, Jiang Guihua, Teknos Theodoros N, Chepeha Douglas B, Bradford Carol R

Abstract excerpt

BACKGROUND: This study was performed to assess the ability of autologous tumor vaccines to induce T-cell reactivity to squamous cell cancers (SCC). METHODS: Irradiated autologous tumor cells admixed with bacillus Calmette-Guérin (BCG) were given intradermally in patients with advanced head and neck cancers. Vaccine-primed lymph node (VPLN) cells were secondarily activated with anti-CD3 mAb and expanded in IL-2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adjuvants, Immunologic
Share to Adoptive Transfer
Share to BCG Vaccine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biopsy, Needle

Share to Cancer Vaccines

Share to Interleukin-2

Share to Palliative Care

Share to Sampling Studies

Source

Identifiers

PMID: 12599287
DOI: 10.1002/hed.10195

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Generation of vaccine-primed lymphocytes for the treatment of head and neck cancer.PMID 12599287Read ↗

Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2.Semantic proximity Read ↗

Immunological effects of BCG as an adjuvant in autologous tumor vaccines.Semantic proximity Read ↗

Phase II trial of autologous tumor vaccination, anti-CD3-activated vaccine-primed lymphocytes, and interleukin-2 in stage IV renal cell cancer.Semantic proximity Read ↗

Clinical observations on adoptive immunotherapy with vaccine-primed T-lymphocytes secondarily sensitized to tumor in vitro.Semantic proximity Read ↗

Expanded tumor-reactive CD4+ T-cell responses to human cancers induced by secondary anti-CD3/anti-CD28 activation.Semantic proximity Read ↗

CD4+ T helper responses in squamous cell carcinoma of the head and neck.Semantic proximity Read ↗

Tumour-infiltrating lymphocytes mediate lysis of autologous squamous cell carcinomas of the head and neck.Semantic proximity Read ↗

Enhancement of anti-tumor immunity specific to murine glioma by vaccination with tumor cell lysate-pulsed dendritic cells engineered to produce interleukin-12.Semantic proximity Read ↗

HLA-A3 restricted mutant ras specific cytotoxic T-lymphocytes induced by vaccination with T-helper epitopes.Semantic proximity Read ↗

Interleukin-2 gene-modified allogeneic tumor cells for treatment of relapsed neuroblastoma.Semantic proximity Read ↗

Efficacy of in vitro sensitized cells generated by in vivo priming with OK-432 for adoptive immunotherapy of the poorly immunogenic B16-Bl6 melanoma.Semantic proximity Read ↗

Augmentation of antitumor immunity in regional lymph nodes by local immunotherapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.